Download as txt, pdf, or txt
Download as txt, pdf, or txt
You are on page 1of 3

Chronic kidney disease (CKD) refers to the slow loss of kidney function over tim e.

As per the severity of the disease, CKD can be classified into five stages, t he fifth being the most severe, in which the kidneys lose nearly all their abili ty to function. This stage is known as End Stage Renal Disease (ESRD). Since ESR D is a progressive diseases and can never be reversed, there are only two option s left for its treatment, either kidney transplantation or dialysis. Dialysis is a process for removing waste from the body, and can be done by two main methods , peritoneal dialysis (PD) or hemodialysis (HD). The dialysis market can also be segmented into dialysis products & dialysis services market. The major dialysis products include dialyzers, hemodialysis machines, along with peritoneal dialys is products. Dialysis services refer to the treatments given by the specialized physicians and care persons to the patients. Diabetes and high blood pressure are the two major reasons for kidney failures a nd the ever increasing cases of both these diseases have led to an increasing nu mber of patients suffering from CKD and consequently end stage renal diseases. S ince dialysis is a long term treatment, and is quite expensive, the increasing i nsurance density is likely to boost up the dialysis market. Also, due to the sho rtage of kidney donors, a significantly large number of ESRD patients are not ab le to get their kidneys transplanted and therefore have to rely only on dialysis for their lifetime. Due to all the above mentioned factors, coupled with some o thers, the dialysis market is likely to grow considerably in the coming years. 1. Introduction 1.1 1.2 1.3 1.4 Chronic Kidney Disease (CKD) End Stage Renal Disease (ESRD) ESRD: Treatment Options Dialysis and its Types

2. Global Dialysis Market 2.1 Market Size 2.2 Dialysis Market Segments 3. US Dialysis Market 4. Market Dynamics 4.1 Key Trends 4.2 Growth Drivers 4.2.1 4.2.2 4.2.3 4.2.4 4.2.5 4.2.6 Diabetic Population Rapidly Ageing Population Increasing Insurance Density Population with High Blood Pressure Increasing Consumption of Illegal or Non-prescription Drugs Shortage of Kidney Donors

5. Key Issues and Challenges 5.1 Risks and Side Effects 5.2 High Associated Costs 6. Dialysis Market - Competitive Landscape 7. Company Profiles 7.1 Fresenius Medical Care

7.2 Baxter International Inc. 7.3 DaVita Inc. 8. Market Outlook for more information view link http://www.konceptanalytics.com/reportDetail.aspx ?reportID=324 website http://www.konceptanalytics.com/ List of Charts Types of Dialysis Worldwide Patients with End Stage Renal Disease (2005-2010) Patients with End Stage Renal Disease Share by Mode of Treatment (2010) Dialysis Patients Worldwide (2005-2010) Global Prevalence Rates of ESRD and Dialysis (2004-2010) Global Dialysis Market Size (2005-2010) Global Dialysis Market Value share by Regions (2010) Global Dialysis Market Value Share by Regions (2015E) Dialysis Clinics Worldwide Share by Type of Operators (2010) Global Dialysis Market Segmental Breakdown by Value (2010) Global Dialysis Products Market (2006-2010) Global Dialysis Services Market (2006-2010) ESRD Incident Rates in the US (2001-2008) Dialysis Population in the US (2001-2008) Share of Type of Dialysis Clinics Worldwide by Regions (2010) World Population with Diabetes, Age Group 20-79 years (2006-2012) Ageing Population Worldwide (age>65) 2005-2015 Global Insurance Density (2003-2009) Percent of Patients on Kidney Transplant Waiting List in the US (2001-2008) Dialysis Products Global Share by Companies (2010) Hemodialysis Products Global Share by Companies (2010) Peritoneal Dialysis Products Global Share by Companies (2010) Top 5 Dialysis Providers Worldwide by Number of Patients Treated (2010) North American Number of Dialysis Patients Treated by Companies (2010) Europe Number of Dialysis Patients Treated by Companies (2010) Asia Pacific Number of Dialysis Patients Treated by Companies (2010) Latin America Number of Dialysis Patients Treated by Companies (2010) Fresenius Revenue (2007-2010) Fresenius Revenue Share by Segments (2010) Fresenius Revenue Breakdown by Geography (2010) Baxter Revenue (2007-2010) Baxter Revenue Share by Segments (2010) Baxter Revenue Share by Geographical Segments (2010) Baxter R&D Investment (2006-2010) DaVita Revenue (2007-2010) DaVita Revenue Share by Segments (2010) Dialysis Market Forecasts (2010-2014E) List of Tables Stages of Chronic Kidney Disease Advantages and Disadvantages of Hemodialysis Advantages and Disadvantages of Peritoneal Dialysis Dialysis Patients by Region (2010) ESRD Medicare and Non-Medicare Spending in the US (2008)

US Dialysis Industry Capacity (2003-2009) US Dialysis Industry Capacity Share by Types (2009) Ten Largest US Renal Providers (2010) US Home Dialysis Patients by Companies (2009 & 2010) Operating Cost of Dialysis Centers-Share Breakdown by Type of Costs in the US Market Position of Companies in Dialysis Market by Product Groups (2010) Dependent & Independent Variables (2005 2009) Correlation Matrix Model Summary Coefficient of Determination Regression Coefficients Output

You might also like